MedsByMe
New York, US · Founded 2017 · Delaware corporation
Founders & leadership
RM
Robert M. Siegel, M.D.Named on SEC filing
Reported raises · per SEC filings
Form D private placements$745K disclosed across 2 rounds · 2017–2020
▶$445KraisedMay 2020 · 6 investors · Other Health CareRule 506(b)
▶$445KraisedMay 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert M. Siegel, M.D.Executive Officer, Director
- Offering amount
- $500K
- Amount sold
- $445K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$300KraisedSep 2017 · 8 investors · Other Health CareRule 506(b)
▶$300KraisedSep 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert M. Siegel, M.D.Executive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $25K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has MedsByMe raised?
- MedsByMe has disclosed $745K raised across 2 rounds.
- Where is MedsByMe headquartered?
- MedsByMe is headquartered in New York, US.